| | Variables | All patients (n = 74) | LAD ≥44 mm (n = 28) | LAD <44 mm (n = 46) | value | All patients (n = 76) | LVEDD ≥43 mm (n = 48) | LVEDD <43 mm (n = 28) | value |
| | Female, n (%) | 39 (52.7) | 14 (50.0) | 25 (54.3) | 0.716 | 39 (51.3) | 21 (43.8) | 18 (64.3) | 0.084 | | Age, yrs | 58.1 ± 14.9 | 60.8 ± 15.6 | 56.4 ± 14.4 | 0.223 | 57.6 ± 15.2 | 57.4 ± 14.9 | 58.0 ± 15.9 | 0.865 | | HTN, n (%) | 21 (28.4) | 7 (25.0) | 14 (30.4) | 0.615 | 21 (27.6) | 16 (33.3) | 5 (17.9) | 0.146 | | DM, n (%) | 11 (14.9) | 4 (14.3) | 7 (15.2) | 0.913 | 11 (14.5) | 9 (18.8) | 2 (7.1) | 0.294 | | CHD, n (%) | 9 (12.2) | 4 (14.3) | 5 (10.9) | 0.663 | 9 (11.8) | 7 (14.6) | 2 (7.1) | 0.548 | | AF, n (%) | 31 (41.9) | 16 (57.1) | 15 (32.6) | 0.038 | 32 (42.1) | 22 (45.8) | 10 (35.7) | 0.389 | | AVB, n (%) | 17 (23.0) | 5 (17.9) | 12 (26.1) | 0.414 | 18 (23.7) | 11 (22.9) | 7 (25.0) | 0.837 | | LVOTO, n (%) | 36 (48.6) | 10 (35.7) | 26 (56.5) | 0.082 | 37 (48.7) | 20 (41.7) | 17 (60.7) | 0.109 | | IVST (mm) | 16.0 (13.0–21.0) | 16.0 (12.3–19.0) | 16.0 (14.0–21.0) | 0.345 | 16.0 (13.0–21.0) | 16.0 (12.0–20.0) | 16.0 (14.0–24.0) | 0.274 | | LAD (mm) | 41.7 ± 7.8 | — | — | — | 41.7 ± 7.8 | 43.8 ± 8.4 | 38.3 ± 5.4 | 0.003 | | LVEDD (mm) | 45.4 ± 6.5 | 48.3 ± 6.5 | 43.7 ± 5.9 | 0.003 | 45.7 ± 6.6 | — | — | — | | LVEF (%) | 63.1 ± 8.8 | 59.9 ± 10.5 | 65.0 ± 7.0 | 0.027 | 63.0 ± 8.7 | 61.2 ± 8.9 | 66.1 ± 7.4 | 0.016 | | Pulmonary hypertension, n (%) | 5 (6.8) | 3 (10.7) | 2 (4.3) | 0.360 | 6 (7.9) | 4 (8.3) | 2 (7.1) | >0.999 | | Severe tricuspid regurgitation, n (%) | 6 (8.1) | 4 (14.3) | 2 (4.3) | 0.191 | 6 (7.9) | 4 (8.3) | 2 (7.1) | >0.999 | | SBP (mmHg) | 120.0 (110.0–131.25) | 120.0 (110.0–133.8) | 120.0 (107.5–131.3) | 0.866 | 120.0 (110.0–130.0) | 120.0 (110.0–130.0) | 120.0 (102.5–137.5) | 0.732 | | DBP (mmHg) | 74.5 (64.8–80.0) | 70.0 (65.5–80.0) | 80.0 (64.8–80.0) | 0.458 | 74.5 (65.8–80.0) | 70.0 (65.8–80.0) | 78.0 (65.5–80.0) | 0.455 | | HR (bpm) | 64.5 (57.8–72.0) | 64.5 (57.8–76.3) | 64.5 (57.8–71.3) | 0.793 | 64.0 (57.3–71.8) | 63.5 (57.3–71.5) | 68.0 (57.8–71.8) | 0.351 | | Medications | | | | | | | | | | Β-blocker, n (%) | 60 (81.1) | 23 (82.1) | 37 (80.4) | 0.856 | 62 (81.6) | 36 (75.0) | 26 (92.9) | 0.053 | | CCB, n (%) | 35 (47.3) | 10 (35.7) | 25 (54.3) | 0.119 | 36 (47.4) | 21 (43.8) | 15 (53.6) | 0.408 | | ACEI/ARB, n (%) | 22 (29.7) | 13 (46.4) | 9 (19.6) | 0.014 | 22 (28.9) | 17 (35.4) | 5 (17.9) | 0.103 | | AMIO, n (%) | 10 (13.5) | 5 (17.9) | 5 (10.9) | 0.616 | 10 (13.2) | 6 (12.5) | 4 (14.3) | 0.999 | | Warfarin, n (%) | 7 (9.5) | 4 (14.3) | 3 (6.5) | 0.268 | 7 (9.2) | 6 (12.5) | 1 (3.6) | 0.250 | | Dual-chamber pacing, n (%) | 64 (86.5) | 21 (75.0) | 43 (93.5) | 0.057 | 65 (85.5) | 39 (81.3) | 26 (92.9) | 0.294 | | RV apical pacing, n (%) | 73 (98.6) | 28 (100.0) | 45 (97.8) | >0.999 | 75 (98.7) | 48 (100.0) | 27 (96.4) | 0.368 |
|
|
Data are presented as mean ± SD, median (interquartiles), or n (%). LAD, left atrial diameter; LVEDD, left ventricular end-diastolic diameter; HTN, hypertension; DM, diabetes mellitus; CHD, coronary heart disease; AF, atrial fibrillation; AVB, atrioventricular block; LVOTO, left ventricular outflow tract obstruction; IVST, interventricular septum thickness; LVEF, left ventricular ejection fraction; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; CCB, calcium-channel blocker; ACEI/ARB, angiotensin-converting enzyme inhibitor/angiotensin-receptor blocker; AMIO, amiodarone; RV, right ventricular.
|
